by Salehi, A. et al.
Department of Neurology and Neurological Sciences, Stanford Medical School, Stanford, CA 94305, USA
Department of Neurology and Neurological Sciences, Stanford Medical School, Stanford, CA 94305, USA
Our findings raise the possibility that restoring norepinephrine-mediated neurotransmission could reverse cognitive dysfunction in Down syndrome.
Sci. Transl. Med. 2009; 7:7ra17